Your session is about to expire
← Back to Search
Contact Lens
Lens B, Then Lens A for Near-sightedness
N/A
Waitlist Available
Led By Lyndon Jones, PhD FCOptom
Research Sponsored by Coopervision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
Study Summary
To evaluate the performance of two monthly replacement silicone hydrogel contact lenses in habitual FRP CL wearers when worn for 1-month.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Lens Handling on Lens Removal
Trial Design
2Treatment groups
Experimental Treatment
Group I: Lens B, Then Lens AExperimental Treatment2 Interventions
Participants wore Lens B for one month and then crossed over to wear Lens A for one month.
Group II: Lens A, Then Lens BExperimental Treatment2 Interventions
Participants wore Lens A for one month and then crossed over to wear Lens B for one month.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lens A (lehfilcon A lens)
2022
N/A
~30
Lens B (comfilcon A lens)
2022
N/A
~30
Find a Location
Who is running the clinical trial?
Coopervision, Inc.Lead Sponsor
155 Previous Clinical Trials
13,803 Total Patients Enrolled
Lyndon Jones, PhD FCOptomPrincipal InvestigatorCentre for Ocular Research and Education
10 Previous Clinical Trials
482 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger